patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: NEWS this am: PSTI Doses First Patient in U.S. With Placenta-Derived Stem Cell
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Tim, the amount of shares involved is miniscule compared to the original one billion shares authorized and in relation to the number of shares currently authorized. I can see the price falling to the price paid by the selected investors, but I do not see it staying there for long. The strike price of the additional options is 1.60 so I see that as a floor in the future. As u say, only need one PR. GL

Kirk

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply